EURL PHARMACIE COPPOLA : revenue, balance sheet and financial ratios

EURL PHARMACIE COPPOLA is a French company founded 19 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in PARIS (75006), this company of category PME shows in 2016 a revenue of 1.4 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - EURL PHARMACIE COPPOLA (SIREN 497645903)
Indicator 2021 2020 2019 2018 2017 2016 2015 2013 2012
Revenue N/C N/C N/C N/C N/C 1 354 872 € 1 156 059 € 1 185 986 € 1 313 652 €
Net income -21 995 € 55 949 € 39 540 € 39 666 € 35 875 € 183 698 € 79 695 € 91 411 € 99 237 €
EBITDA N/C N/C N/C N/C N/C 290 833 € 227 465 € 136 784 € 145 794 €
Net margin N/C N/C N/C N/C N/C 13.6% 6.9% 7.7% 7.6%

Revenue and income statement

In 2021, EURL PHARMACIE COPPOLA records a net loss of 22 k€. This deficit will reduce equity on the balance sheet.

Net income (2021) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-21 995 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 127%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 28%. The balance between equity and debt is satisfactory.

Debt ratio (2021) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

126.972%

Financial autonomy (2021) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

28.414%

Solvency indicators evolution
EURL PHARMACIE COPPOLA

Sector positioning

Debt ratio
126.97 2021
2019
2020
2021
Q1: 29.04
Med: 85.54
Q3: 208.43
Average

In 2021, the debt ratio of EURL PHARMACIE COPPOLA (126.97) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
28.41% 2021
2019
2020
2021
Q1: 25.89%
Med: 44.41%
Q3: 64.18%
Average -5 pts over 3 years

In 2021, the financial autonomy of EURL PHARMACIE COPPOLA (28.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2021) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2021) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2021) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2021) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
EURL PHARMACIE COPPOLA

Positioning of EURL PHARMACIE COPPOLA in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare EURL PHARMACIE COPPOLA with other companies in the same sector:

Frequently asked questions about EURL PHARMACIE COPPOLA

What is the revenue of EURL PHARMACIE COPPOLA ?

The revenue of EURL PHARMACIE COPPOLA in 2016 is 1.4 M€.

Is EURL PHARMACIE COPPOLA profitable?

EURL PHARMACIE COPPOLA recorded a net loss in 2021.

Where is the headquarters of EURL PHARMACIE COPPOLA ?

The headquarters of EURL PHARMACIE COPPOLA is located in PARIS (75006), in the department Paris.

Where to find the tax return of EURL PHARMACIE COPPOLA ?

The tax return of EURL PHARMACIE COPPOLA is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does EURL PHARMACIE COPPOLA operate?

EURL PHARMACIE COPPOLA operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.